Patellofemoral Joint Degenerative Joint Disease with Joint Line Spurring
Patellofemoral joint osteoarthritis with spurring is a distinct entity from tibiofemoral OA that requires specific clinical recognition and a stepwise treatment approach starting with non-operative management (exercise, weight loss, NSAIDs) and progressing to surgical options only when conservative measures fail.
Pathophysiology and Causes
Patellofemoral joint DJD results from cartilage degeneration of the patella and trochlea, triggered by chronic overload and abnormal biomechanics 1. Joint line spurring (osteophytes) represents advanced disease with bony remodeling.
Key causative factors include:
- Patellar malalignment or maltracking
- Trochlear dysplasia
- Patellar instability (MPFL injury)
- Lower limb malalignment (particularly valgus)
- Prior patellar trauma or ACL surgery
- Obesity and endocrine disorders 2, 1
Clinical Features
Distinctive symptoms and signs of patellofemoral OA with spurring:
Symptoms:
- Anterior knee pain aggravated by stairs (especially descending), squatting, prolonged sitting
- History of dramatic swelling episodes 3
- Difficulty with activities that load the patellofemoral joint
Physical examination findings:
- Pain on patellar compression (grind test)
- Coarse crepitus with patellofemoral motion
- Valgus deformity (not varus, which indicates tibiofemoral OA)
- Reduced quadriceps strength
- Positive apprehension test if instability present 2, 3
Critical distinction: Classic signs of knee OA—effusion, bony enlargement, reduced flexion ROM, mediolateral instability, and varus deformity—are predominantly manifestations of tibiofemoral OA, NOT isolated patellofemoral disease 3.
Diagnostic Approach
Imaging is NOT required for typical presentations 4. However, when imaging is needed:
First-line: Plain radiographs 4
Advanced imaging (CT/MRI) reserved for:
Do not perform routine imaging for follow-up—only image if unexpected rapid progression or change in clinical characteristics occurs 4.
Management Algorithm
Step 1: Non-Operative Management (First-Line for All Patients)
The 2019 ACR/Arthritis Foundation guideline provides the framework 6:
Strong recommendations:
- Exercise programs (particularly quadriceps strengthening)
- Weight loss if BMI >25
- Topical NSAIDs for knee OA
- Oral NSAIDs when topical insufficient
- Intraarticular glucocorticoid injections
Conditional recommendations:
- Patellofemoral bracing specifically for patellofemoral OA 6
- Kinesiotaping
- Acetaminophen (weak evidence)
- Duloxetine for chronic pain
- Tramadol (use cautiously)
Additional evidence-based options:
- Cold therapy and thermal modalities
- Hyaluronic acid injections 2
- PRP and regenerative therapies (emerging evidence) 2
- Radiofrequency ablation for refractory pain 6, 2
Step 2: Surgical Management (When Conservative Fails)
Surgical algorithm based on disease severity and patient factors 2, 7:
Arthroscopic assessment (initial surgical option)
- Address mechanical symptoms
- Lateral soft tissue release if indicated
- Remove overhanging lateral osteophytes (spurring)
Tibial tubercle osteotomy (TTO)
- For patients <50 years OR active patients >50 years
- Corrects malalignment
- Addresses patellar instability
Patellofemoral arthroplasty (PFA)
- For severe, refractory disease
- Modern implants show improved outcomes
- Consider when other options exhausted
Critical Caveats
Contraindications to certain treatments:
- Severe lateral PFJ degeneration may limit UKA outcomes if tibiofemoral disease also present 8
- Lateral patellar subluxation and lateral trochlear osteophytes require correction before arthroplasty 8
- Patellar bone marrow edema on MRI indicates more advanced disease requiring aggressive management 8
Common pitfalls:
- Treating patellofemoral OA like tibiofemoral OA—they are distinct entities requiring different approaches
- Ordering routine follow-up imaging (not indicated per guidelines) 4
- Missing malalignment or instability as underlying causes requiring surgical correction 2, 1
- Proceeding to surgery without adequate trial of conservative management
Imaging features do NOT predict non-surgical treatment response—do not use imaging to guide conservative treatment decisions 4.